Symbol: |
VSTM2L
|
Description: |
V-set and transmembrane domain containing 2 like [Source:HGNC Symbol;Acc:16096]
|
Location: |
Chr20:36531499-36573752[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:128
Gene |
Compound |
Gen_sig |
Exp_pattern |
VSTM2L |
NSC 29182 |
0.007 |
Up |
VSTM2L |
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester |
0.001 |
Down |
VSTM2L |
Cycloalkannin |
0.02 |
Up |
VSTM2L |
1-Propanone, 3-(dimethylamino)-2-[(dimethylamino)methyl]-1-(4-methoxyphenyl)-, dihydrochloride |
0.038 |
Up |
VSTM2L |
CHALCONE ANALOG |
0.012 |
Up |
VSTM2L |
Tesimide |
0.026 |
Up |
VSTM2L |
1,2-Naphthoquinone, 3,7-dimethyl- |
0.02 |
Up |
VSTM2L |
NSC 406433 |
0.025 |
Up |
VSTM2L |
9-AC |
0.036 |
Up |
VSTM2L |
Camptothecin ethylglycinate ester hydrochloride |
0.04 |
Up |
VSTM2L |
Camptothecin hemisuccinate sodium salt |
0.014 |
Up |
VSTM2L |
NSC 611074 |
0.014 |
Up |
VSTM2L |
NSC 614053 |
0.015 |
Up |
VSTM2L |
Benzoic acid, 2-hydroxy-, (2,6-pyridinediyldiethylidyne)dihydrazide, manganese chloride complex |
0.035 |
Down |
VSTM2L |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.042 |
Down |
Expression pattern: Sensitivity / Resistance
Total:9 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:16
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|